Patent · US Active

Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission

US8188301B2 · kind B2 · utility

1Cited by

5References

13Claims

0Family size

Assignee

NSAB, Filial af Neurosearch Sweden AB, Sverige · DK

Inventors

Clas Sonesson · Lindome, SE
Lars Swanson · Partille, SE
Fredrik Pettersson · Handen, SE
Nicholas Waters · Handen, SE
Susanna Waters · Handen, SE

Key dates

Filing date	Jun 4, 2008
Grant date	May 29, 2012
Priority date	—
Expiry date	Jun 4, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of compounds which increase extracellular levels of catecholamines, dopamine and norepinephrine, in cerebral cortical areas of the mammalian brain, and more specifically to the use of 3-disubstituted phenyl-1-pyrrolidinols for the treatment of central nervous system disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.